Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGSWW) Non-Current Deffered Revenue (2020 - 2021)

GeneDx Holdings has reported Non-Current Deffered Revenue over the past 2 years, most recently at $295.0 million for Q2 2021.

  • Quarterly results put Non-Current Deffered Revenue at $295.0 million for Q2 2021, changed N/A from a year ago — trailing twelve months through Jun 2021 was $295.0 million (changed N/A YoY), and the annual figure for FY2020 was $132.0 million, changed.
  • Non-Current Deffered Revenue for Q2 2021 was $295.0 million at GeneDx Holdings, down from $297.0 million in the prior quarter.
  • Over the last five years, Non-Current Deffered Revenue for WGSWW hit a ceiling of $297.0 million in Q1 2021 and a floor of $15.5 million in Q3 2020.